1
Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy Volunteers
Condition(s):HealthyLast Updated:September 18, 2009Completed
Nisoldipine as an Intervention: 6 Clinical Trials
Hide Studies Not Open or Pending
2
Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg
Condition(s):HealthyLast Updated:September 28, 2009Completed
3
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
Condition(s):Diabetic NephropathyLast Updated:April 6, 2006Completed
4
Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg
Condition(s):HealthyLast Updated:August 8, 2008Completed
5
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension
Condition(s):HypertensionLast Updated:May 26, 2008Completed
6
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
Condition(s):Hypertension; COVIDLast Updated:April 28, 2021Completed